Feb 14, 2024, 09:04 AM by

Personalized Health Basel and Leading Life Sciences Organization Collaborate with MDClone to Drive Innovation

Feb 14, 2024, 00:00 AM by User Not Found

Bio-IT World | Researchers in California have shown that breast cancer patients with RNA expression levels of ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) in the bottom 50th percentile can confidently be treated with Keytruda (pembrolizumab) as well as surgery. Their cancer would have a zero percent chance of metastasizing in seven years.

Feb 13, 2024, 11:15 AM by

In 2022, the latest data from the International Agency for Research on Cancer's Global Cancer Observatory indicates that ten specific types of cancer collectively represented approximately two-thirds of both new cases and fatalities worldwide. Covering 185 countries and 36 different types of cancer, the rising demand for biologics, including monoclonal antibodies and immunotherapies, has surged due to the increasing incidence of cancer. These innovative treatments are revolutionizing cancer care by enhancing survival rates and minimizing adverse effects.

Feb 13, 2024, 11:15 AM by

Domainex, a leading drug discovery and integrated medicines research partner based in Cambridge UK, opens a new Biology Centre of Excellence to further support collaborations with pharmaceutical and biotechnology companies, patient foundations and leading academic institutions globally.

Feb 13, 2024, 01:00 AM by User Not Found

Bio-IT World | Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health have created a next-generation sequencing (NGS) technology that employs oligonucleotides (oligos)—short single strands of synthetic DNA—as bait for relevant targets of detection.

Feb 9, 2024, 09:16 AM by

BioTeam, Inc. has been awarded a contract by the National Human Genome Research Institute (NHGRI) to enhance its data ecosystem, accelerating genomic discoveries and improving human health outcomes.

Feb 9, 2024, 09:16 AM by

Abzena launches LabZient™, an analytical platform accelerating antibody development timelines by combining predictive in-silico evaluation with laboratory methods. LabZient™ streamlines assessment, reduces costs, and enables early measurement of critical quality attributes. Fit-for-purpose across various antibody types, including mAbs and ADCs, LabZient™ enhances efficiency in biopharma development.

Feb 9, 2024, 09:16 AM by

Feb 9, 2024, 01:00 AM by User Not Found

Bio-IT World | In biopharma R&D there is growing momentum around the use of Generative AI, the deep-learning algorithms capable of distilling complex knowledge into easily digestible summaries. But so far companies have been relatively modest in their ambitions for the technology.

Feb 8, 2024, 08:17 AM by

Today ZeOmega, a population health management company, was named Best in KLAS for Payer Care Management Solutions for the third consecutive year. The newly released 2024 Best in KLAS: Software & Services Report recognized ZeOmega as a leader in its market category. This designation follows a record growth year in 2023 that included: 94% client retention, 16% client base expansion New tech partners (such as Microsoft) to enhance automation capabilities Product innovations and AI implementations that address care quality, utilization management, member engagement, and risk adjustment

Feb 8, 2024, 08:17 AM by

Cotiviti announced they won 2024 Best in KLAS: Software & Services for its Quality Intelligence solution, which enables health plans to track, monitor, and improve quality compliance. With top feedback from its clients and other healthcare executives, Cotiviti earned the highest ratings in five of KLAS’s Customer Experience Pillars.

Feb 8, 2024, 08:17 AM by

Visit booth 70 at Rocky Mountain ISPE Vendor Show and booth 943 at ISPE CaSA Annual Tech Show to meet Watson-Marlow engineers and discuss the company’s expert fluid path solutions

Feb 8, 2024, 08:17 AM by

Devens, MA, US / 30th January 2023 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range specially designed for medical devices and diagnostic instruments at MD&M West in Anaheim, CA, from February 6-8.

Feb 8, 2024, 08:17 AM by

Feb 7, 2024, 08:10 AM by

Feb 7, 2024, 08:10 AM by

Feb 7, 2024, 08:09 AM by

London, UK, 7th February 2024 / Sciad Newswire / MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, is embarking on a collaborative project with the Centre for Public Health at Queen’s University Belfast (QUB) in Northern Ireland to develop data-driven diagnostic tools for Diabetic Kidney Disease (DKD). The two-year project is partially funded by a grant recently awarded to MultiOmic Health under Innovate UK’s £20 million Advancing Precision Medicine programme, supporting industry-led research projects to enable more accurate diagnosis and treatment stratification within the UK National Health Service (NHS).

Feb 7, 2024, 08:09 AM by

Feb 7, 2024, 08:09 AM by

Feb 7, 2024, 08:09 AM by